1-2 of 2
on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

James D. Best, MD, Paul L. Drury, FRACP, Timothy M.E. Davis, MRCP, Marja-Riitta Taskinen, MD, Y. Antero Kesäniemi, MD, Russell Scott, PHD, Christopher Pardy, BSC, Merryn Voysey, MBIOSTAT, Anthony C. Keech, FRACP, on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
Journal: Diabetes Care
Diabetes Care 2012;35(5):1165–1170
https://doi.org/10.2337/dc11-1307
Published: 11 April 2012
View article titled, Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: <subtitle>Real-world diabetes therapy in a clinical trial cohort</subtitle>
Open the PDF for Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: <subtitle>Real-world diabetes therapy in a clinical trial cohort</subtitle> in another window
Includes: Supplementary data
Journal Articles

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Russell Scott, MB CHB, PHD, FRACP, Richard O'Brien, MB, PHD, FRACP, Greg Fulcher, MB, MD, FRACP, Chris Pardy, Michael d'Emden, MB BS, PHD, FRACP, Dana Tse, PHD, Marja-Riitta Taskinen, MD, Christian Ehnholm, MD, PHD, Anthony Keech, MB BS, FRACP, MSC(EPID), on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
Journal: Diabetes Care
Diabetes Care 2009;32(3):493–498
https://doi.org/10.2337/dc08-1543
Published: 01 March 2009
View article titled, Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: <subtitle>The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study</subtitle>
Open the PDF for Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: <subtitle>The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study</subtitle> in another window
Includes: Supplementary data